The standard glow peptide dosage is 2,000 to 2,500 mcg per day, administered as a single subcutaneous injection. "Glow peptide" is a branded blend combining three peptides in one vial: GHK-Cu (copper peptide), BPC-157, and TB-500 in a typical 5:1:1 ratio.
The name comes from GHK-Cu's documented ability to stimulate collagen and elastin synthesis, which produces visible skin improvements. The addition of BPC-157 and TB-500 extends the blend's effects to tissue repair and wound healing.
| Quick Reference | Details |
|---|---|
| Product | Glow peptide (GHK-Cu + BPC-157 + TB-500 blend) |
| Standard daily dose | 2,000-2,500 mcg total blend |
| Component ratio | 5:1:1 (GHK-Cu : TB-500 : BPC-157) |
| Common vial sizes | 42 mg and 70 mg |
| Administration | Subcutaneous injection, once daily |
| Timing | Morning recommended |
| Cycling | 4 weeks on, 2-4 weeks off |
| Skin results timeline | 1-4 weeks |
| Tissue repair timeline | 4-8 weeks |
| FDA approved? | No (none of the components are FDA-approved) |
This article covers dosage protocols for both vial sizes, what each component does, reconstitution math, cycling schedules, and expected timelines.
This is educational content about research peptides. Consult a healthcare provider for any medical treatment needs.
Get your custom peptide protocol:
- Tailored to your body and goals
- Precise dosing and cycle length
- Safe stacking combinations
- Backed by peer-reviewed studies
- Ready in under 2 minutes
What Is the Glow Peptide?
The glow peptide is a pre-mixed blend of three research peptides sold in a single vial. It is not a single molecule. The blend combines:
- GHK-Cu (copper peptide): A naturally occurring tripeptide first discovered in 1973 by Loren Pickart in human plasma. GHK-Cu is the primary active component and the source of the "glow" name. It stimulates collagen, elastin, and glycosaminoglycan synthesis. Research has shown it modulates over 4,000 genes related to tissue repair and regeneration.
- BPC-157: A 15 amino acid peptide derived from gastric juice. BPC-157 promotes angiogenesis (new blood vessel formation), stimulates fibroblast activity, and accelerates collagen formation. It is primarily known for tendon, ligament, and GI tissue repair.
- TB-500: A synthetic fragment of thymosin beta-4. TB-500 enhances actin regulation and fibroblast migration, supporting tissue regeneration and wound healing.
The three peptides target overlapping but distinct repair pathways. GHK-Cu drives the skin rejuvenation. BPC-157 and TB-500 support deeper tissue repair. Together, the blend addresses both cosmetic skin improvements and structural healing.
For a detailed analysis of how these three peptides work together, see our GHK-Cu + BPC-157 + TB-500 blend guide.
Dosage Protocol
The standard glow peptide dosage depends on vial size. Two configurations are common in the research peptide market.
70 mg Vial Protocol
The 70 mg vial contains 50 mg GHK-Cu + 10 mg TB-500 + 10 mg BPC-157.
| Parameter | Details |
|---|---|
| Reconstitution | Add 3 mL bacteriostatic water |
| Concentration | 23.3 mg/mL total blend |
| Daily dose | 10 units (0.10 mL) on an insulin syringe |
| Daily GHK-Cu | ~1,670 mcg |
| Daily BPC-157 | ~333 mcg |
| Daily TB-500 | ~333 mcg |
| Total daily | ~2,333 mcg |
| Vial lasts | 30 days |
For reconstitution guidance, use our reconstitution calculator.
42 mg Vial Protocol
The 42 mg vial contains 27 mg GHK-Cu + 10 mg TB-500 + 5 mg BPC-157.
| Parameter | Details |
|---|---|
| Reconstitution | Add 2 mL bacteriostatic water |
| Concentration | 21 mg/mL total blend |
| Daily dose | 7 units (0.07 mL) on an insulin syringe |
| Daily GHK-Cu | ~1,350 mcg |
| Daily BPC-157 | ~250 mcg |
| Daily TB-500 | ~500 mcg |
| Total daily | ~2,100 mcg |
| Vial lasts | ~28 days |
Both vial configurations deliver a total daily dose in the 2,000 to 2,500 mcg range. The 70 mg vial provides higher GHK-Cu proportionally, which may be preferable for skin-focused research.
Individual Component Dosages
When sourcing components separately rather than as a pre-mixed blend, the individual target dosages are:
| Component | Daily Target | Role |
|---|---|---|
| GHK-Cu | 1,500-2,000 mcg | Collagen/elastin stimulation, gene modulation |
| BPC-157 | 250-500 mcg | Tissue repair, angiogenesis |
| TB-500 | 250-500 mcg | Cell migration, wound healing |
These ranges align with published research protocols and the ratios used in commercial blends. Sourcing individually gives you control over the exact ratio and allows adjustment based on whether your research priorities are skin rejuvenation (increase GHK-Cu) or tissue repair (increase BPC-157/TB-500).
For detailed dosing of each component, see our individual guides: - GHK-Cu dosage guide - GHK-Cu injection frequency - BPC-157 dosage for 200 lb male - TB-500 mechanism and uses
Cycling Protocol
The standard cycling protocol for the glow peptide is 4 weeks on, followed by 2 to 4 weeks off. This cycling approach is based on two considerations.
First, receptor sensitivity. Continuous daily administration of any peptide can lead to receptor downregulation, where receptors become less responsive over time. The off-period allows receptor sensitivity to reset.
Second, collagen synthesis timing. Collagen turnover in the skin takes approximately 4 to 6 weeks for a full cycle. Running the peptide for 4 weeks initiates a wave of collagen production that continues during the off-period. Many users report that skin improvements continue to develop during the rest phase.
| Phase | Duration | Protocol |
|---|---|---|
| Loading | 4 weeks | Daily injection, 2,000-2,500 mcg |
| Rest | 2-4 weeks | No peptide administration |
| Maintenance | 4 weeks | Resume daily injection |
| Long-term | Repeat cycles | Continue 4 on / 2-4 off pattern |
Morning injection is recommended. Inject subcutaneously into the lower abdomen (rotating injection sites) using an insulin syringe.
For proper storage, reconstituted peptides should be refrigerated at 36 to 46 degrees Fahrenheit and used within 28 to 30 days. See our peptide storage guide and reconstituted peptide shelf life guide.
Expected Timeline
Results vary by individual, but the glow peptide blend typically produces effects on two timelines.
| Timeline | Expected Changes |
|---|---|
| Week 1-2 | Subtle skin texture improvement, mild hydration increase |
| Week 2-4 | Visible "glow" effect, improved skin tone, reduced fine lines |
| Week 4-6 | Collagen density increase measurable, skin elasticity improvement |
| Week 6-8 | Tissue repair effects from BPC-157/TB-500 become apparent |
| Week 8-12 | Cumulative improvement across multiple cycles |
The GHK-Cu component drives the earliest visible changes (skin glow and texture). BPC-157 and TB-500 effects on deeper tissue repair take longer to manifest. If using the blend for recovery from injury or surgery, expect 4 to 8 weeks for meaningful tissue repair effects.
For topical applications of GHK-Cu (microneedling, serums), see our GHK-Cu microneedling guide and GHK-Cu nasal spray guide.
Safety and Regulatory Status
None of the three glow peptide components are FDA-approved for any indication. GHK-Cu is classified as Category 2, which restricts it from 503A compounding pharmacies. This classification means legitimate compounding pharmacies cannot prepare GHK-Cu for individual patient prescriptions.
Known considerations for each component:
- GHK-Cu: Generally well-tolerated in research. May cause mild irritation at injection sites. Theoretical concern about stimulating growth in existing cancers (due to angiogenic properties), though no clinical evidence supports this.
- BPC-157: No completed human clinical trials. Safety profile derived from animal studies. GI side effects are uncommon. See our BPC-157 safety considerations.
- TB-500: Similar to BPC-157, safety data comes primarily from animal and in vitro studies.
For a comprehensive overview of peptide safety, see our peptide safety guide. For information on the regulatory landscape, see our FDA peptide crackdown analysis.
Frequently Asked Questions
What is glow peptide?
Glow peptide is a branded blend of three research peptides: GHK-Cu (copper peptide), BPC-157, and TB-500 in a typical 5:1:1 ratio. The name comes from GHK-Cu's ability to stimulate collagen and elastin production, which produces visible skin 'glow.' Common vial sizes are 42 mg and 70 mg.
What is the correct glow peptide dosage?
The standard dosage is 2,000 to 2,500 mcg total blend per day, administered as a single subcutaneous injection. For a 70 mg vial reconstituted with 3 mL bacteriostatic water, this equals 10 units (0.10 mL) on an insulin syringe. Inject once daily, morning preferred.
How do you reconstitute glow peptide?
For a 70 mg vial, add 3 mL bacteriostatic water. For a 42 mg vial, add 2 mL. Inject the water slowly along the vial wall. Gently swirl (do not shake). Refrigerate immediately. Use within 28-30 days. Use our reconstitution calculator for exact measurements.
How long does glow peptide take to work?
Skin improvements (glow, texture, hydration) typically appear within 1-4 weeks. Deeper tissue repair effects from BPC-157 and TB-500 take 4-8 weeks. Collagen density increases are measurable after 4-6 weeks. Results continue to develop during off-cycle periods.
How long should you cycle glow peptide?
The standard protocol is 4 weeks on, followed by 2-4 weeks off. This cycling pattern prevents receptor downregulation and allows collagen synthesis to continue during the rest phase. Repeat the cycle for sustained results.
Can you use GHK-Cu, BPC-157, and TB-500 separately instead?
Yes. Individual components can be sourced separately and combined. Target daily doses: GHK-Cu 1,500-2,000 mcg, BPC-157 250-500 mcg, TB-500 250-500 mcg. Separate sourcing allows ratio adjustment but requires more complex reconstitution math.
The Bottom Line
The glow peptide blend delivers a daily dose of 2,000 to 2,500 mcg combining GHK-Cu, BPC-157, and TB-500. The 70 mg vial reconstituted with 3 mL bacteriostatic water provides 30 days of daily injections at 10 units per dose. Cycle 4 weeks on, 2 to 4 weeks off.
GHK-Cu drives the skin rejuvenation effects that give the blend its name. BPC-157 and TB-500 add tissue repair capabilities. Expect visible skin improvements within 1 to 4 weeks and deeper tissue effects within 4 to 8 weeks.
Use our reconstitution calculator for exact measurements, and see our GHK-Cu dosage guide and GHK-Cu + BPC-157 + TB-500 blend guide for deeper component analysis.
This is educational content about research peptides. None of these compounds are FDA-approved. Consult a healthcare provider for any medical treatment needs.
Not Sure Which Peptide Protocol Is Right for You?
Take our 2-minute quiz for a personalized recommendation based on your goals and health profile.
Start the Quiz →